Combination of omalizumab and bee venom immunotherapy: does it work?
Asia Pacific Allergy
;
(4): e2-2018.
Artigo
em Inglês
| WPRIM
| ID: wpr-750131
ABSTRACT
Bee venom immunotherapy (b-VIT) can be combined with omalizumab therapy in order to suppress systemic reactions developing due to b-VIT itself. Omalizumab acts as a premedication and gains time for the immunotherapy to develop its immunomodulatory effects. However, the combination of omalizumab and b-VIT is not always effective enough. Herein we present a patient in whom successful immunotherapy cannot be achieved with combination of omalizumab to b-VIT.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pré-Medicação
/
Venenos de Abelha
/
Abelhas
/
Omalizumab
/
Anafilaxia
/
Imunoterapia
Limite:
Humanos
Idioma:
Inglês
Revista:
Asia Pacific Allergy
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS